Neurofibromatosis 2 News and Research

RSS
Mouse model for human malignant mesothelioma

Mouse model for human malignant mesothelioma

Mouse model tightly matches pediatric tumor syndrome, will speed drug hunt

Mouse model tightly matches pediatric tumor syndrome, will speed drug hunt

Researchers identify cells that cause nervous system disease

Researchers identify cells that cause nervous system disease

Neurofibromatosis 1 gene drives pivotal decision in early brain development

Neurofibromatosis 1 gene drives pivotal decision in early brain development

Existing drugs may be useful in treating brain tumors

Existing drugs may be useful in treating brain tumors

Zorro-LNA stops genetic disorders in their tracks

Zorro-LNA stops genetic disorders in their tracks

Shutting down microglia

Shutting down microglia

Developing brain tumors coax assistance from nearby cells

Developing brain tumors coax assistance from nearby cells

Statin drug reverses learning and attention deficits in a mouse model of the genetic disorder Neurofibromatosis type I

Statin drug reverses learning and attention deficits in a mouse model of the genetic disorder Neurofibromatosis type I

Novel technique to remove tumors from the cervical region of the spine

Novel technique to remove tumors from the cervical region of the spine

Drugs known as farnesyltransferase inhibitors (FTIs) may hold promise for premature aging disorder

Drugs known as farnesyltransferase inhibitors (FTIs) may hold promise for premature aging disorder

High risk of second cancers in survivors of childhood soft tissue sarcomas

High risk of second cancers in survivors of childhood soft tissue sarcomas

Potential treatments for neurofibromatosis

Potential treatments for neurofibromatosis

Key proteins that regulate neurofibromatosis could be targets for new drugs

Key proteins that regulate neurofibromatosis could be targets for new drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.